The global ophthalmic eye drop market is set to grow from USD 17,271.8 million in 2024 to USD 25,876.4 million by 2034, at a CAGR of 4.7% over the forecast period. This growth is driven by the increasing prevalence of eye disorders, the growing aging population, and the expanding need for innovative and effective treatments for various ophthalmic conditions such as glaucoma, dry eyes, and conjunctivitis.
In 2023, the ophthalmic eye drop market was valued at USD 16,390.6 million, and it is anticipated to exhibit a year-on-year growth of 5.4% in 2024. The demand for ophthalmic eye drops has been rising due to the growing awareness of eye health, advancements in drug formulations, and the increasing availability of over-the-counter eye care products. The market is benefiting from a rising inclination toward non-invasive treatments, as eye drops provide a convenient and efficient way to deliver therapeutic agents to the eye.
The surge in eye conditions linked to aging populations, such as age-related macular degeneration (AMD) and cataracts, is a key factor driving market demand. Additionally, the growing adoption of prescription eye drops for treating chronic conditions like glaucoma is expected to support sustained market expansion.
Key Takeaways:
- The global ophthalmic eye drop market is projected to grow from USD 17,271.8 million in 2024 to USD 25,876.4 million by 2034, with a CAGR of 4.7%.
- In 2023, the market was valued at USD 16,390.6 million, with a year-on-year growth of 5.4% expected in 2024.
- The growing prevalence of eye disorders and the aging population are key drivers of the market’s expansion.
- Advances in eye drop formulations and the increasing availability of non-invasive treatment options contribute to rising demand for ophthalmic eye care products.
Key Growth Drivers
- Increasing Prevalence of Ocular Diseases: The rising incidence of conditions such as glaucoma, dry eye syndrome, and age-related macular degeneration is driving demand for ophthalmic eye drops.
- Advancements in Eye Drop Formulations: Innovations in formulations and delivery systems are enhancing the effectiveness and convenience of eye drops, making them more appealing to consumers.
- Growing Awareness and Accessibility: Increased awareness regarding eye health and improved access to ophthalmic treatments are contributing to market growth.
Market Dynamics
- The market encompasses various types of eye drops used for treating different ocular conditions, with a significant focus on prescription and over-the-counter products.
- Distribution channels include retail pharmacies, online platforms, and hospitals, with e-commerce showing notable growth due to changing consumer preferences.
Challenges
Despite the positive outlook, the market faces challenges such as:
- Regulatory Hurdles: Compliance with stringent regulations can complicate product approvals and market entry.
- Competition from Alternative Treatments: The availability of alternative therapies may impact the demand for traditional eye drops.
Competitive Landscape
In the dynamic ophthalmic eye drop market landscape, companies strategically emphasize collaborations, partnerships, and continuous product launches. These initiatives reflect the industry’s commitment to innovation, addressing evolving market demands, and staying competitive. Instances of key developmental strategies by industry players in the ophthalmic eye drop market are given below:
- In May 2023, Bausch & Lomb and Novaliq jointly announced that MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) received FDA approval for effectively treating the signs and symptoms associated with dry eye disease.
- In May 2021, Scope Eyecare and URSAPHARM Arzneimittel GmbH announced a collaboration to produce a co-branded product line for dry eye products in the United States. The OPTASE® HYLO® range was created to fulfill the needs of dry eye patients in the United States.
Key Companies Profiled
- Allergan
- Novartis AG (Sandoz Inc.)
- Alcon Laboratories, Inc.
- Bausch Health US LLC
- Viatris Inc.
- Teva Pharmaceuticals
- Sun Pharmaceutical Industries, Inc.
- URSAPHARM Arzneimittel GmbH
- Lupin Biomedical Group
- Biomedical Group
- AdvaCare Pharma
- Dompé Farmaceutici S.p.A
Get the Comprehensive Full Report Now
Ophthalmic Eye Drop Industry Segmentation by Category
By Product:
- Anesthetic Drops
- Dilation Drops
- Glaucoma Drops
- Steroid Drops
- Antibiotic Drops
- Others
By Indication:
- Dry Eye
- Eye Allergy
- Glaucoma
- Eye Infection
- Retinal Disorders
- Macular Degeneration
- Diabetic Retinopathy
- Others
- Uveitis
- Others
By Drug Formulation:
- With Preservative
- Preservative Free
By Container Type:
- Single Dose Container
- Multiple-dose Container
By Distribution Channel:
- Institutional Sales
- Hospitals
- Community Clinics
- Ophthalmic Clinics
- Public Health Agencies
- Veterinary Hospitals & Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacy
By Region:
- North America
- Latin America
- East Asia
- South Asia and Pacific
- Western Europe
- Eastern Europe
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
